Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million

Friday, June 7, 2019 1 min read

Key Takeaway: Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million

Full Press Release Details

Biogen Completes Acquisition of Nightstar Therapeutics for Approximately $800 Million.